MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models

ABSTRACT As efforts to study the mechanisms of melanoma metastasis and novel therapeutic approaches multiply, researchers need accurate, high‐throughput methods to evaluate the effects on tumor burden resulting from specific interventions. We show that automated quantification of tumor content from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pigment cell and melanoma research 2025-01, Vol.38 (1), p.e13195-n/a
Hauptverfasser: Karz, Alcida, Coudray, Nicolas, Bayraktar, Erol, Galbraith, Kristyn, Jour, George, Shadaloey, Arman Alberto Sorin, Eskow, Nicole, Rubanov, Andrey, Navarro, Maya, Moubarak, Rana, Baptiste, Gillian, Levinson, Grace, Mezzano, Valeria, Alu, Mark, Loomis, Cynthia, Lima, Daniel, Rubens, Adam, Jilaveanu, Lucia, Tsirigos, Aristotelis, Hernando, Eva
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACT As efforts to study the mechanisms of melanoma metastasis and novel therapeutic approaches multiply, researchers need accurate, high‐throughput methods to evaluate the effects on tumor burden resulting from specific interventions. We show that automated quantification of tumor content from whole slide images is a compelling solution to assess in vivo experiments. In order to increase the outflow of data collection from preclinical studies, we assembled a large dataset with annotations and trained a deep neural network for the quantitative analysis of melanoma tumor content on histopathological sections of murine models. After assessing its performance in segmenting these images, the tool obtained consistent results with an orthogonal method (bioluminescence) of measuring metastasis in an experimental setting. This AI‐based algorithm, made freely available to academic laboratories through a web‐interface called MetFinder, promises to become an asset for melanoma researchers and pathologists interested in accurate, quantitative assessment of metastasis burden. A schematic depicting the overall approach in designing MetFinder. Created with BioRender.com.
ISSN:1755-1471
1755-148X
1755-148X
DOI:10.1111/pcmr.13195